Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What downside volume Guardant Health GH 035 20260429 MKL Markel Group posts massive Q1 2026 EPS miss even as shares edge 039 percent higher in todays trading ORIQ Origin CEO highlights planned portfolio diversification in comments accompanying latest quarterly earnings SCEM SCE Trust releases latest quarterly earnings no core financial performance data disclosed to investors yet AIRelated Layoffs as a Stock Catalyst The Market May Not Agree Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model US Jobless Claims Remain Near Historic Lows in Latest Week SoftBanks Ambitious AI Initiative Attracts Leading Japanese Manufacturers On Holding Executives and Founder Increase Stake in Company Indian Equities Conclude Week in Positive Territory Amidst USIran Diplomacy Pineapple Financial Inc PAPL Q3 2025 Earnings Narrowing Losses Beat Expectations Yet Shares Slip Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Redwood Trust Inc 9500 Senior Notes Due 2030 RWTQ Q1 2026 Earnings EPS Falls Short Amid Challenging Market Conditions HIW Q1 2026 Earnings Massive EPS Surprise of 161 Drives Stock Rally OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 Stock Declines AirJoule Technologies AIRJ Surges 9 Key Support and Resistance Levels to Watch Kratos Defense Security Solutions KTOS Shows Resilience with 110 Gain Testing Key Resistance Levels Expedia Group EXPE Softens as Travel Sector Faces Headwinds Key Levels to Watch First Internet Bancorp INBK Retreats Slightly as Stock Tests Nearby Support Levels STRK Preferred Shares Edge Higher Consolidating Near Resistance Modular Medical Inc MODD Q3 2025 Earnings EPS Miss Weighs Despite Positive Stock Reaction Scholar Rock Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops DTI Q1 2026 Earnings EPS Misses Expectations as Stock Declines Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances